Valeant to acquire Solta Medical for $236 million-Reuters
Valeant Pharmaceuticals International said on Monday that it would buy Solta Medical Inc for about $236 million in cash to add products for procedures such as skin rejuvenation, skin tightening and body contouring, Reuters reported.
16 December 2013•2 mins read
